Today's Change
+0.85%
AI Sentiment
59%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with neutral sentiment across 14 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $KTTAW | Pasithea Therapeutics Corp - Warrants (11/08/2026) | -1.23% |
| $DRMAW | Dermata Therapeutics Inc - Warrants (13/08/2026) | -8.87% |
| $TMCWW | TMC the metals company Inc - Warrants (09/09/2026) | +60.68% |
| $ENGNW | enGene Holdings Inc - Warrants (31/10/2028) | +11.50% |
| $HUMAW | Humacyte Inc - Warrants (27/08/2026) | +5.13% |
| $SDSTW | Stardust Power Inc - Warrants (21/06/2029) | -2.69% |
| $SCLXW | Scilex Holding Company - Warrants (10/11/2027) | -6.43% |
| $NBY | NovaBay Pharmaceuticals, Inc. | +0.00% |
| $SBFMW | Sunshine Biopharma Inc - Warrants (15/02/2027) | +0.00% |
| $NAMSW | NewAmsterdam Pharma Company NV - Warrants (15/11/2027) | +21.31% |
| $CDTTW | Conduit Pharmaceuticals Inc Wt Exp | +65.33% |
| $SABSW | SAB Biotherapeutics Inc - Warrants (25/07/2027) | +48.52% |
| $ERNAW | Ernexa Therapeutics Inc Warrants | +63.87% |
| $RVMDW | Revolution Medicines Inc - Warrants (17/12/2026) | +4.86% |
| $CINGW | Cingulate Inc - Warrants (03/12/2026) | -10.38% |
Materials News
805 articles
GlobeNewswire Inc.38d ago
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.38d ago
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc.38d ago
ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.38d ago
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.38d ago
Did You Lose Money Investing in Atara Biotherapeutics, Inc.? Robbins LLP Encourages Investors with Significant Losses to Contact the Firm About Their Rights Against ATRA
Benzinga38d ago
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
GlobeNewswire Inc.38d ago
CORT INVESTOR UPDATE: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
GlobeNewswire Inc.38d ago
ImmunityBio, Inc. (IBRX) Faces Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out -- Hagens Berman
GlobeNewswire Inc.38d ago
Coty Inc. (COTY) Faces Securities Class Action Amid Surprise YoY Deterioration in Operating Income, CEO Departure, Withdrawn Guidance -- Hagens Berman
GlobeNewswire Inc.38d ago
ADMA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
GlobeNewswire Inc.38d ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX
Market Sentiment
Neutral
59% Sentiment Score
Sector Stats
Total Stocks198
News Today14
Avg Volume1.3M
AI SentimentNeutral